Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 10.19 Amended and Restated Research Collaboration and License Agreement Between Tango Therapeutics, Inc. and Gilead Sciences, Inc., Dated August 17, 2020
- 10.20 License Agreement Between Tango Therapeutics, Inc. and Medivir Ab, Dated March 12, 2020
- 23.1 Consent of Withumsmith+brown, PC, Independent Registered Public Accounting Firm of BCTG Acquisition Corp
- 23.2 Consent of Pricewaterhousecoopers LLP, Independent Registered Public Accounting Firm of Tango Therapeutics, Inc
- 99.1 Form of Proxy Card
- 99.9 Consent of Canaccord Genuity LLC
- Download Excel data file
- View Excel data file
Associated filings
- 19 Jul 21 EFFECT Notice of effectiveness
- 19 Jul 21 424B3 Prospectus supplement
- 16 Jul 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 2 Jul 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
17 Jun 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 19 Apr 21 S-4 Registration of securities issued in business combination transactions
TNGX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Amendment No. 1 to Form S-4 of our report dated March 31, 2021, relating to the financial statements of BCTG Acquisition Corp., which is contained in that Prospectus. We also consent to the reference to our Firm under the caption “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC | |
New York, New York | |
June 16, 2021 |